Literature DB >> 17339329

The polycomb group protein Suz12 is required for embryonic stem cell differentiation.

Diego Pasini1, Adrian P Bracken, Jacob B Hansen, Manuela Capillo, Kristian Helin.   

Abstract

Polycomb group (PcG) proteins form multiprotein complexes, called Polycomb repressive complexes (PRCs). PRC2 contains the PcG proteins EZH2, SUZ12, and EED and represses transcription through methylation of lysine (K) 27 of histone H3 (H3). Suz12 is essential for PRC2 activity and its inactivation results in early lethality of mouse embryos. Here, we demonstrate that Suz12(-/-) mouse embryonic stem (ES) cells can be established and expanded in tissue culture. The Suz12(-/-) ES cells are characterized by global loss of H3K27 trimethylation (H3K27me3) and higher expression levels of differentiation-specific genes. Moreover, Suz12(-/-) ES cells are impaired in proper differentiation, resulting in a lack of repression of ES cell markers as well as activation of differentiation-specific genes. Finally, we demonstrate that the PcGs are actively recruited to several genes during ES cell differentiation, which despite an increase in H3K27me3 levels is not always sufficient to prevent transcriptional activation. In summary, we demonstrate that Suz12 is required for the establishment of specific expression programs required for ES cell differentiation. Furthermore, we provide evidence that PcGs have different mechanisms to regulate transcription during cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17339329      PMCID: PMC1899991          DOI: 10.1128/MCB.01432-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Epigenetic dynamics of imprinted X inactivation during early mouse development.

Authors:  Ikuhiro Okamoto; Arie P Otte; C David Allis; Danny Reinberg; Edith Heard
Journal:  Science       Date:  2003-12-11       Impact factor: 47.728

Review 2.  In vitro differentiation of embryonic stem cells.

Authors:  G M Keller
Journal:  Curr Opin Cell Biol       Date:  1995-12       Impact factor: 8.382

3.  A gene product required for correct initiation of segmental determination in Drosophila.

Authors:  G Struhl
Journal:  Nature       Date:  1981-09-03       Impact factor: 49.962

4.  Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.

Authors:  Diego Pasini; Adrian P Bracken; Michael R Jensen; Eros Lazzerini Denchi; Kristian Helin
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

5.  Maintenance of mouse trophoblast stem cell proliferation by TGF-beta/activin.

Authors:  Adrian Erlebacher; Kelly A Price; Laurie H Glimcher
Journal:  Dev Biol       Date:  2004-11-01       Impact factor: 3.582

6.  SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex.

Authors:  Ru Cao; Yi Zhang
Journal:  Mol Cell       Date:  2004-07-02       Impact factor: 17.970

7.  EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.

Authors:  Adrian P Bracken; Diego Pasini; Maria Capra; Elena Prosperini; Elena Colli; Kristian Helin
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

8.  Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells.

Authors:  David C Hay; Linda Sutherland; John Clark; Tom Burdon
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

9.  E(z): a polycomb group gene or a trithorax group gene?

Authors:  D LaJeunesse; A Shearn
Journal:  Development       Date:  1996-07       Impact factor: 6.868

10.  The eed mutation disrupts anterior mesoderm production in mice.

Authors:  C Faust; A Schumacher; B Holdener; T Magnuson
Journal:  Development       Date:  1995-02       Impact factor: 6.868

View more
  357 in total

1.  Distinct epigenomic landscapes of pluripotent and lineage-committed human cells.

Authors:  R David Hawkins; Gary C Hon; Leonard K Lee; Queminh Ngo; Ryan Lister; Mattia Pelizzola; Lee E Edsall; Samantha Kuan; Ying Luu; Sarit Klugman; Jessica Antosiewicz-Bourget; Zhen Ye; Celso Espinoza; Saurabh Agarwahl; Li Shen; Victor Ruotti; Wei Wang; Ron Stewart; James A Thomson; Joseph R Ecker; Bing Ren
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

Review 2.  Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2.

Authors:  Chiara Mozzetta; Julien Pontis; Slimane Ait-Si-Ali
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

3.  ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.

Authors:  Hua Li; Benjamin G Bitler; Vinod Vathipadiekal; Marie E Maradeo; Michael Slifker; Caretha L Creasy; Peter J Tummino; Paul Cairns; Michael J Birrer; Rugang Zhang
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-05

4.  PRC2 directly methylates GATA4 and represses its transcriptional activity.

Authors:  Aibin He; Xiaohua Shen; Qing Ma; Jingjing Cao; Alexander von Gise; Pingzhu Zhou; Gang Wang; Victor E Marquez; Stuart H Orkin; William T Pu
Journal:  Genes Dev       Date:  2012-01-01       Impact factor: 11.361

5.  PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes.

Authors:  Zhonghua Gao; Jin Zhang; Roberto Bonasio; Francesco Strino; Ayana Sawai; Fabio Parisi; Yuval Kluger; Danny Reinberg
Journal:  Mol Cell       Date:  2012-02-10       Impact factor: 17.970

Review 6.  Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer.

Authors:  Martin Sauvageau; Guy Sauvageau
Journal:  Cell Stem Cell       Date:  2010-09-03       Impact factor: 24.633

7.  The JARID2-PRC2 duality.

Authors:  Hans-Martin Herz; Ali Shilatifard
Journal:  Genes Dev       Date:  2010-05       Impact factor: 11.361

8.  High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis.

Authors:  K C Kawabata; Y Hayashi; D Inoue; H Meguro; H Sakurai; T Fukuyama; Y Tanaka; S Asada; T Fukushima; R Nagase; R Takeda; Y Harada; J Kitaura; S Goyama; H Harada; H Aburatani; T Kitamura
Journal:  Leukemia       Date:  2017-07-19       Impact factor: 11.528

9.  Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination.

Authors:  Katharina Steinmann; David N Cooper; Lan Kluwe; Nadia A Chuzhanova; Cornelia Senger; Eduard Serra; Conxi Lazaro; Montserrat Gilaberte; Katharina Wimmer; Viktor-Felix Mautner; Hildegard Kehrer-Sawatzki
Journal:  Am J Hum Genet       Date:  2007-10-31       Impact factor: 11.025

10.  Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus.

Authors:  Yan Liu; Fan Liu; Hao Yu; Xinyang Zhao; Goro Sashida; Anthony Deblasio; Michael Harr; Qing-Bai She; Zhenbang Chen; Hui-Kuan Lin; Silvana Di Giandomenico; Shannon E Elf; Youyang Yang; Yasuhiko Miyata; Gang Huang; Silvia Menendez; Ingo K Mellinghoff; Neal Rosen; Pier Paolo Pandolfi; Cyrus V Hedvat; Stephen D Nimer
Journal:  Sci Signal       Date:  2012-10-23       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.